|
1
|
Yan L, Xu MT, Yuan L, Chen B, Xu ZR, Guo
QH, Li Q, Duan Y, Huang Fu, Wang YJ, et al: Prevalence of
dyslipidemia and its control in type 2 diabetes: A multicenter
study in endocrinology clinics of China. J Clin Lipidol.
10:150–160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu Y, Wang L, He J, Bi Y, Li M, Wang T,
Wang L, Jiang Y, Dai M, Lu J, et al: 2010 China Noncommunicable
Disease Surveillance Group: Prevalence and control of diabetes in
Chinese adults. JAMA. 310:948–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Christiansen J, Kolte AM, Hansen Tv and
Nielsen FC: IGF2 mRNA-binding protein 2: Biological function and
putative role in type 2 diabetes. J Mol Endocrinol. 43:187–195.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nielsen J, Christiansen J, LykkeAndersen
J, Johnsen AH, Wewer UM and Nielsen FC: A family of insulin-like
growth factor II mRNA-binding proteins represses translation in
late development. Mol Cell Biol. 19:1262–1270. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun XJ, Rothenberg P, Kahn CR, Backer JM,
Araki E, Wilden PA, Cahill DA, Goldstein BJ and White MF: Structure
of the insulin receptor substrate IRS-1 defines a unique signal
transduction protein. Nature. 352:73–77. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nandi A, Kitamura Y, Kahn CR and Accili D:
Mouse models of insulin resistance. Physiol Rev. 84:623–647. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sesti G, Federici M, Hribal ML, Lauro D,
Sbraccia P and Lauro R: Defects of the insulin receptor substrate
(IRS) system in human metabolic disorders. FASEB J. 15:2099–2111.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saxena R, Hivert MF, Langenberg C, Tanaka
T, Pankow JS, Vollenweider P, Lyssenko V, BouatiaNaji N, Dupuis J,
Jackson AU, et al: GIANT consortium; MAGIC investigators: Genetic
variation in GIPR influences the glucose and insulin responses to
an oral glucose challenge. Nat Genet. 42:142–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Irwin N and Flatt PR: Therapeutic
potential for GIP receptor agonists and antagonists. Best Pract Res
Clin Endocrinol Metab. 23:499–512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yi F, Brubaker PL and Jin T: TCF-4
mediates cell type-specific regulation of proglucagon gene
expression by beta-catenin and glycogen synthase kinase-3beta. J
Biol Chem. 280:1457–1464. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Villareal DT, Robertson H, Bell GI,
Patterson BW, Tran H, Wice B and Polonsky KS: TCF7L2 variant
rs7903146 affects the risk of type 2 diabetes by modulating
incretin action. Diabetes. 59:479–485. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
American Diabetes Association. Diagnosis
and classification of diabetes mellitus. Diabetes Care. 33(Suppl
1): S62–S69. 2010.PubMed/NCBI
|
|
13
|
Dupont WD and Plummer WD Jr: Power and
sample size calculations. A review and computer program. Control
Clin Trials. 11:116–128. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chistiakov DA, Nikitin AG, Smetanina SA,
Bel'chikova LN, Suplotova LA, Shestakova MV and Nosikov VV: The
rs11705701 G>A polymorphism of IGF2BP2 is associated with
IGF2BP2 mRNA and protein levels in the visceral adipose tissue - a
link to type 2 diabetes susceptibility. Rev Diabet Stud. 9:112–122.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Allayee H, Xiang AH, Trigo E,
Hartiala J, Lawrence JM, Buchanan TA and Watanabe RM: Variation in
IGF2BP2 interacts with adiposity to alter insulin sensitivity in
Mexican Americans. Obesity (Silver Spring). 17:729–736. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Diabetes Genetics Initiative of Broad
Institute of Harvard and MIT, Lund University, and Novartis
Institutes of BioMedical Research, . Saxena R, Voight BF, Lyssenko
V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S,
Hirschhorn JN, et al: Genome-wide association analysis identifies
loci for type 2 diabetes and triglyceride levels. Science.
316:1331–1336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang Y-C, Liu P-H, Yu Y-H, Kuo SS, Chang
TJ, Jiang YD, Nong JY, Hwang JJ and Chuang LM: Validation of type 2
diabetes risk variants identified by genome-wide association
studies in Han Chinese population: A replication study and
meta-analysis. PLoS One. 9:e950452014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lasram K, Ben Halim N, Benrahma H,
Mediene-Benchekor S, Arfa I, Hsouna S, Kefi R, Jamoussi H, Ben
Ammar S, Bahri S, et al: Contribution of CDKAL1 rs7756992 and
IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic
complications, obesity risk and hypertension in the Tunisian
population. J Diabetes. 7:102–113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
AlSinani S, Woodhouse N, AlMamari A,
AlShafie O, AlShafaee M, AlYahyaee S, Hassan M, Jaju D, AlHashmi K,
AlAbri M, et al: Association of gene variants with susceptibility
to type 2 diabetes among Omanis. World J Diabetes. 6:358–366. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu J, Wu J, Zhou Y, Zou H, Guo S, Liu J,
Lu L and Xu H: Quantitative assessment of the variation in IGF2BP2
gene and type 2 diabetes risk. Acta Diabetologica. 49(Suppl 1):
S87–S97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sonestedt E, Lyssenko V, Ericson U,
Gullberg B, Wirfält E, Groop L and Orho-Melander M: Genetic
variation in the glucose-dependent insulinotropic polypeptide
receptor modifies the association between carbohydrate and fat
intake and risk of type 2 diabetes in the Malmo Diet and Cancer
cohort. J Clin Endocrinol Metab. 97:E810–E818. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saxena R, Hivert MF, Langenberg C, Tanaka
T, Pankow JS, Vollenweider P, Lyssenko V, BouatiaNaji N, Dupuis J,
Jackson AU, et al: Genetic variation in GIPR influences the glucose
and insulin responses to an oral glucose challenge. Nat Genet.
42:142–148. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Voight BF, Scott LJ, Steinthorsdottir V,
Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS,
Thorleifsson G, et al: Twelve type 2 diabetes susceptibility loci
identified through large-scale association analysis. Nat Genet.
42:579–589. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haupt A, Thamer C, Heni M, Ketterer C,
Machann J, Schick F, Machicao F, Stefan N, Claussen CD, Häring HU,
et al: Gene variants of TCF7L2 influence weight loss and body
composition during lifestyle intervention in a population at risk
for type 2 diabetes. Diabetes. 59:747–750. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dou H, Ma E, Yin L, Jin Y and Wang H: The
association between gene polymorphism of TCF7L2 and type 2 diabetes
in Chinese Han population: A meta-analysis. PLOS One. 8:e594952013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lou XY, Chen GB, Yan L, Ma JZ, Zhu J,
Elston RC and Li MD: A generalized combinatorial approach for
detecting gene-by-gene and gene-by-environment interactions with
application to nicotine dependence. Am J Hum Genet. 80:1125–1137.
2007. View
Article : Google Scholar : PubMed/NCBI
|
